On the contrary, in some cancers such as in leukemia, MMP-2 and MMP-9 bind to CD44 in a complex where MMP-14, interacting with CD44v6, cleaves and activates MMP-2, inducing the degradation of the extracellular matrix [49]. This evidence concerns the gene MMP2 and leukemia.